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INTRODUCTION
The Lewis histo-blood group system consists of 2 major
antigens-Lea and Leb-and 3 common phenotypes-Le(a-b-),
Le(a+b-), and Le(a-b+). The Lea antigen is synthesized
from a type 1 precursor substrate by the Lewis-encoded
a-(1,3/1,4)-fucosyltransferase, while the Leb antigen is syn-
thesized from a type 1 H substrate. There are 2 alleles at
the Lewis locus, Le, which encodes a functional fucosyl-
transferase, and le, which encodes a nonfunctional enzyme.
The Le59 allele confers approximately the same level of en-
zymatic activity as the Le allele [1]. The le59,508 and le59,1067
alleles confer very low enzymatic activity as compared to
the Le and Le59 alleles [2]. Lewis phenotype is determined
by the combination of the Lewis/Secretor genotype. An
individual homozygous for le expression has neither the
Lea nor the Leb antigen. Secretors have at least 1 functional
Se allele, while non-secretors are homozygous for non-
functional se alleles. Several polymorphisms in the Lewis
and Secretor genes have been reported [1-7]. Frequent
polymorphisms in Koreans were 357C>T and 385A>T in
the Secretor gene and 59T>G and 508G>A in the Lewis
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gene [8, 9]. 
Carbohydrate antigen 19-9 (CA 19-9), which is equiva-
lent to the sialyl Lewis antigen, is a well-known tumor
marker for pancreatic cancer [10]. Healthy individuals with
an Lea-positive secretor status may show physiologically
elevated CA 19-9 concentrations in all types of secretions
(e.g. sputum, saliva, bronchial/gastric secretions, bile juice,
etc), in contrast to patients with a Lewis(a-b-) status, who
have little or no CA 19-9 in their serum [11]. Usually, CA
19-9 is detected at low concentrations (<40 kU/L) in the
serum of healthy individuals. 
In this study, we examined the Lewis/Secretor genotypes
and serum CA 19-9 levels, and evaluated the relationship
between these 2 factors in a Korean population. We aimed




A total of 242 individuals (161 men and 81 women) with-
out any malignancy who had visited the health promotion
center at Seoul National University Bundang Hospital, Kor-
ea, between January 1, and March 8, 2004 were enrolled
in this study. The Seoul National University Bundang Hos-
pital institutional review board approved this study. The
DNA used to determine the Lewis and Secretor genotypes
was extracted using a Puregene DNA Kit (Gentra, Minnea-
polis, MN, USA).
2. Genotyping for the Lewis gene
The Lewis genotyping was performed for the 59T>G,
508G>A, and 1067T>A polymorphic sites. The 59T>G muta-
tion was determined by PCR with confronting two-pair
primers (PCR-CTPP) [12]. In brief, PCR-CTPP is a geno-
typing method that uses 4 primers with similar melting
temperatures. By changing the annealing temperature,
different sized products are amplified on the basis of allele
specificity, which can easily be visualized by gel electro-
phoresis. This lowers the cost and shortens genotyping
times because enzymatic digestion is not required [12]. The
oligonucleotide primer sequences (Bioneer Corporation,
Daejeon, Korea) and experimental conditions used in the
PCR-CTPP have been previously reported [13]. The 508G>A
and 1067T>A mutations were determined by PCR and res-
triction fragment length polymorphism (PCR-RFLP) anal-
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Gene Forward/reverse Primer sequence
Lewis Le59-F1 5′-CCA TGG ATC CCC TGG GTG-3′
Le59-R1 5′-CCA CCA GCA GCT GAA ATA GCC-3′
Le59-F2 5′-CGC TGT CTG GCC GCA CT-3′
Le59-R2 5′-GAA GGT GGG AGG CGT GAC TTA-3′
Le508-F 5′-ACT TGG AGC CAC CCC CTA ACT GCC A-3′
Le508-R 5′-TGA GTC CGG CTT CCA GTT GGA CAC C-3′
Le1067-F1 5′-CTC CCG ACA GGA CAC CAC TCC CA-3′
Le1067-R1 5′-CTC AAG CTT CGT GCC GTG ATG ATC TCT CTG CAC-3′
Le1067-F2 5′-CGC TCC TTC AGC TGG GCA CTG GA-3′
Le1067-R2 5′-CGG CCT CTC AGG TGA ACC AAG AAG CT-3′
Secretor Se357-F1 5′-CTC GAA TTC GGG CCT CCA TCT CCC AGC TAA C-3′
Se357-R1 5′-CTC AAG CTT GCT TCT CAT GCC CGG GCA CTC-3′
Se357-F2 5′-CAG GAT CCC CTG GCA GAA CTA CCA CAT TAA-3′
Se357-R2 5′-AGC AGG GGT AGC CGG TGA AGC GGA CGT ACT-3′
Se385-F0 5′-TTT CAC TGC CAC CAG CAC CTG-3′
Se385-F1 5′-ATC AAA GGC ACT GGG ACC CAG-3′
Se385-R1 5′-GGA CGT ACT CCC CCG GGA T-3′
Se385-F2 5′-TGG AGG AGG AAT ACC GCC ACT-3′
Se385-R2 5′-GTC CCC TCG GCG AAC ATG G-3′
Table 1. Primer sequences for Lewis/Secretor genotyping by PCR-RFLP
ysis. The primer sequences for determining the 508G>A
and 1067T>A mutations were reported previously [2, 4]. 
3. Genotyping for the Secretor gene
The Secretor genotype was determined for the 357C>T
and 385A>T mutations and the fusion gene. The sefus allele
is due to the fusion of the Secretor gene and a pseudogene.
The 357C>T mutation was determined by PCR-RFLP. The
357C>T mutation was detected by performing the first PCR
amplification with the primers previously reported [4]. The
385A>T mutation and fusion gene were detected by PCR-
CTPP genotyping [12], using primers that have been pre-
viously reported [14]. The methods for detecting mutations
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Secretor 385A>T genotyping. A common band of 460 bp appeared for the A and T alleles. (E) Determination of C and T alleles for the
Secretor 357C>T genotype. The second PCR product (98 bp) was cleaved by Ase I digestion to confirm Secretor 357C>T genotype.
Lanes 1-4, TT; lane 5, CT.
Abbreviations: PCR-CTPP, PCR with the confronting two-pair primers; PCR-RFLP, PCR and restriction fragment length polymorphism.
Fig. 1. The electrophoretic patterns of PCR-CTPP and PCR-RFLP.
Lane M was a DNA size marker. (A) Determination of Lewis 59T>
G genotype. Alleles T and G were characterized by amplification
bands of 329 and 81 bp, respectively. A common band of 373 bp
appeared for both alleles. (B) The 206 bp product was cleaved by
Pvu II digestion in order to determine the Lewis 508G>A geno-
type. Lanes 1 and 3, GG; lanes 2 and 4, GA. (C) The second PCR
product (109 bp) was cleaved by Hind III enzymatic digestion to
determine the Lewis 1067T>A mutation. Lanes 1 and 3, TT; lane
2, TA. (D) The amplification products of 284 bp, 216 bp, and 353
bp represented the A, T, and fusion allele, respectively in the
in the Se gene using these primer sets have been described
previously [15]. Primer sequences are listed in Table 1, and
the representative electrophoretic patterns of PCR-RFLP
and PCR-CTPP are shown in Fig. 1.
4. Determination of serum CA 19-9 concentrations
The serum CA 19-9 concentrations were analyzed using
an electrochemiluminescence immunoassay kit on the Mod-
ular Analytics E 170 module (Roche Diagnostics Corporation,
Indianapolis, IN, USA), according to the manufacturer’s
instructions.
5. Statistical analysis
The data were analyzed by Mann-Whitney U test and
Kruskal-Wallis test. All significance tests performed were
two-tailed, and P values <0.05 were considered statisti-
cally significant. All statistical analyses were carried out
using the SPSS 12.0 statistical software program (SPSS,
Chicago, IL, USA). 
RESULTS
The individuals enrolled in this study consisted of 161 men
and 81 women with a mean age of 50.7 yr (range, 26-72 yr).
The distribution of Lewis genotypes within the study group
is described in Table 2. Individuals carrying the 3 common
genotypes-Le/Le, Le/le59,508, and Le/le59,1067-accounted for
95% of the study population. Five individuals (2.1%) were
heterozygous for Le59 (Le/Le59) and 7 (2.9%) were homozy-
gous for le59,508 or le59,10677, the Lewis genotypes with little
enzymatic activity. Table 3 shows the differences in the
allelic frequencies of the Lewis gene among various popu-
lations-Korean, African, Caucasian, Japanese, Chinese,
and Taiwanese. In the Korean population, the allelic fre-
quencies of Le, Le59, le59,508, and le59,1067 were 0.731, 0.010,
0.223, and 0.035, respectively.
The 242 subjects were classified into 9 genotype groups
according to their Lewis/Secretor genotypes (Table 4). There
was a significant difference in the serum CA 19-9 concen-
trations among the 9 genotype groups (P<0.001). 
Serum CA 19-9 was not detected in any of the subjects
that were homozygous for le (genotype groups 7-9; 2.9%,
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The allele Le indicates a functional allele and le a nonfunctional allele (-, not examined).



















Le 0.731 0.500 0.675 0.607 0.750 0.675 0.682
Le59 0.010 0.000 0.020 0.000 0.011 0.026 -
le59,508 0.223 0.310 0.010 0.275 0.145 0.140 -
le59,1067 0.035 0.025 0.130 0.114 0.054 0.123 -
le508 0.000 0.000 0.000 0.000 0.000 0.000 0.128
le1067 0.000 0.000 0.005 0.003 0.004 0.010 0.139
Le304 - 0.020 0.005 - - - -
Le370 - 0.005 0.000 - - - -
le202 - 0.015 0.010 - 0.000 0.000 0.000
le202,314 - 0.080 0.140 - 0.036 0.026 0.051
le202,314,484 - 0.000 0.005 - - - -
le484,667 - 0.025 0.000 - - - -
le484,667,808 - 0.020 0.000 - - - -









Table 2. Distribution of Lewis genotypes in a Korean population
7/242 subjects). Among the individuals with at least 1 func-
tional Le allele, there were only 5 (2.1%) subjects homozy-
gous for the functional Se allele (genotype groups 5 and
6). The remaining subjects (95.0%, 230/242 subjects) were
in genotype groups 1-4 (Le/- and se/-). The 9 genotypes
were grouped into 3 groups according to the combination
of functional genotypes of the Lewis and Secretor genes:
Le/- and se/se (genotype groups 1 and 2), Le/- and Se/-
(genotype groups 3-6), and le/le and -/- (genotype groups
7-9). The serum CA 19-9 levels in subjects from genotype
groups 1 and 2 (Le/- and se/se) were higher than those from
genotype groups 3-6 (Le/- and Se/-; P<0.001) (Table 5).
DISCUSSION
The majority (97.1%) of Korean subjects had at least 1
functional Le allele (Le/- or Le59/-). Seven individuals (2.9%)
were homozygous for the nonfunctional le allele (le/le), which
is a low proportion when compared with that from other
ethnic populations: 22.0% in Xhosa, 9.0% in Caucasians,
8.6% in Taiwanese, 15.5% in Thai, and 12.0% in Filipinos
[16, 17]. In Koreans patients with gastric cancer, approxi-
mately 10.5% (6/57 patients) have been reported to be ho-
mozygous for the le/legenotype [9]; however, our data, which
includes the Lewis/Secretor genotyping, were derived from
a large number of subjects who did not have any malignan-
cy. For the Secretor gene, 6 alleles-Se, Se357, se385, se357/385,
se428, and sefus-have been reported in the Korean popula-
tion [15, 18]. The nonfunctional se428 (428G>A) allele acco-
unted for the majority of the Secretor gene polymorphisms
in Caucasian and African populations [3, 19]. However, it
was previously reported that this mutation is extremely
rare in Koreans [15]. Therefore, this study did not investi-
gate the 428G>A mutation in the Secretor gene. 
The serum CA 19-9 levels in the 9 genotype groups were
compared to the Lewis/Secretor genotypes. Previous reports
suggest that the status of Lewis/Secretor genotypes can
be determined by serum CA 19-9 levels [20, 21]. Nonpara-
metric statistical methods were used to investigate the dis-
tribution of CA 19-9 concentrations, since these concentra-
tions were not distributed in a Gaussian manner. With the
exception of genotype group 5, the CA 19-9 levels decreased
in the 9 genotype groups, with the highest levels observed
in group 1 and the lowest levels observed in group 9. This
is similar to the results of other studies [20, 21]. The CA
19-9 levels in genotype group 5 were higher than the val-
ues inferred from a previous study [21]. Genotype group 5
only consisted of 3 subjects (1.2%); however, the cause of
the elevated CA 19-9 levels is unknown. These results may
be outliers or a genotype-specific result within the Korean
population. Further studies should recruit more subjects
belonging to genotype group 5 to identify the cause of these
results. In this study, only 2.1% (5/242) of the subjects were
in genotype groups 5 and 6 (Le/- and Se/Se), which when
compared with the 32.6% reported in Caucasians, is very a
low percentage of study participants [21]. The difference
in the genotype distribution of the Lewis/Secretor genes
may be due to ethnic specificities.
Seven subjects with the le/le genotype (genotype groups
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CA 19-9 (kU/L)Genotype groups
N
Lewis Secretor Median Range URL
1 Le/Le se/se 33 16.21 5.87-79.25 15.01
2 Le/le se/se 32 13.88 <0.60-35.09 48.06
3 Le/Le Se/se 88 7.13 0.78-31.03 6.65
4 Le/le Se/se 77 5.95 <0.60-27.79 18.02
5 Le/Le Se/Se 3 13.21 12.52-25.15 -
6 Le/le Se/Se 2 1.99 <0.60-3.38 -
7 le/le Se/Se 1 <0.60 - -
8 le/le Se/se 5 <0.60 - -
9 le/le se/se 1 <0.60 - -
Table 4. Lewis/Secretor genotype-specific values for serum CA
19-9*
*There was a significant difference in the serum CA 19-9 concentrations
among the 9 genotype groups (P<0.001).






7, 8, 9 le/le and -/- 7 <0.60 - -
1, 2 Le/- and se/se 65 15.63 <0.60-79.25 36.65
3, 4, 5, 6 Le/- and Se/- 170 6.64 <0.60-31.03 20.30
Table 5. Comparison of the serum CA 19-9 concentrations ac-
cording to Lewis/Secretor genotype groups
*Genotype groups are same as in Table 1.
URL, Upper reference limit is the nonparametrically calculated 0.975 fra-
ctile.
7-9) showed undetectable serum levels of CA 19-9. This
suggests that CA 19-9 serum levels are influenced by the
homozygous Lewis genotype (le/le), which has little enzy-
matic activity. Although most serum CA 19-9 levels fell
within the reference range, there was a significant differ-
ence between the genotype groups Le/- and se/se and Le/-
and Se/-, with significantly higher CA 19-9 serum levels
in the Le/- and se/se genotype group.
We should also consider the fact that subjects with at
least 1 functional Le allele and 1 functional Se allele (geno-
type groups 3-6, 170 persons) expressed low levels of CA
19-9 in serum, with the median and the 0.975 fractile value
as 6.64 and 20.30 kU/L, respectively. 
This study examined the genotypes of the Lewis/Secre-
tor genes and the serum CA 19-9 levels. Because serum CA
19-9 levels are significantly influenced by the Lewis/Secretor
genotypes, caution is suggested when interpreting the se-
rum CA 19-9 levels.
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